ÌÇÐÄÆƽâ°æ

Distribution of views on the risk of measles returning and vaccine autonomy in the United States as of 2026, by 2024 presidential vote

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2025

Region

United States

Survey time period

March 13 to 18, 2026

Number of respondents

3,851 respondents

Age group

18 years and older

Method of interview

Online survey

Supplementary notes

The question was worded in the source as: " There have been reports of diseases that were once eliminated in America, for example measles, returning as a result of people choosing not to receive vaccines. Which of the following comes closest to your view? "

Numbers may not sum to 100 due to rounding.

Citation formats

Views on having vaccine autonomy versus disease risk in the U.S. 2026, by vote

Published by ÌÇÐÄÆƽâ°æ Research Department, Jun 16, 2026

According to a survey conducted in March 2026, almost ** respondents who voted for Donald Trump in 2024 believed the return of measles was a price worth paying to give people a choice to get vaccinated or not. While less than a of Kamala Harries voters felt the same way.

Experts state the risk of outbreaks of diseases such as measles increases considerably when vaccination levels drop below 90 percent. In 2025, the number of measles cases in the U.S. reached its highest annual figure since 1992.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Vaccine hesitancy in the U.S.Pharmaceutical industry in the U.S.Geriatric health in the U.S.Children's health in the U.S.Diseases
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.